Browse by Medical Category
Accepting New Patients
Please note locations: General GI clinic Tuesday mornings on Yawkey 6; Neurogastroenterology clinic Wednesday mornings on Warren 11; pediatric endoscopy suite Tuesday and Wednesday afternoons and some Fridays on Gray 4.
Go To Programs
MassGeneral Hospital for Children
Go To Specialties
As director of the multidisciplinary Neurogastroenterology Program at MassGeneral Hospital for Children (MGHfC), Jaime-Belkind Gerson, MD, MSc, evaluates hospitalized and ambulatory pediatric patients with chronic intestinal neurological disorders. Dr. Belkind-Gerson focuses on motility (motion and function through the GI tract) and sensory diseases of the gastrointestinal tract, including irritable bowel syndrome, functional disorders, congenital malformations, intestinal pseudo-obstruction, intractable constipation, Hirschsprung's disease and other conditions.Dr. Belkind-Gerson is also director of the pediatric gastrointestinal motility laboratory. The lab's goal is to bring the best in testing from the adult motility field into effective testing for children, including a wireless motility capsule and advanced manometry procedures (during manometry a thin, pressure-sensitive tube is inserted through your nose down through the esophagus into the stomach).As an MGHfC fellow and junior faculty, Dr. Belkind-Gerson was part of the research lab that identified ENS-derived neural stem cells in the gut, leading to new therapeutic possibilities. Dr. Belkind-Gerson received his medical degree from the Universidad Nacional Autonoma de Mexico in 1989 and returned to his native country for eight years to found a pediatric gastroenterology department in a hospital in a severely underserved area of south-central Mexico before returning to MassGeneral in 2010.
View my most recent publications at PubMed
Recent news reports have brought about concern over PEG3350, a common ingredient in laxatives used to relieve constipation in children. Jaime Belkind-Gerson, MD, medical director of Pediatric Neurogastroenterology and Nutrition, answers common questions about PEG3350, its safety and its use in children.
Isolation, Characterization and Transplant of intestinal-Derived Neural Stem Cells as a Treatment for Intestinal Neuropathies
Learn more about Dr. Allan Goldstein’s mission to find a cure for this rare colon disease effecting newborns.
Back to Top